Better Coronavirus Stock: AstraZeneca or Moderna?

Only three coronavirus vaccine candidates with the potential to be marketed in the U.S. are currently in late-stage testing. AstraZeneca (NYSE: AZN) and Moderna (NASDAQ: MRNA) claim two of the three.

If you think that these two stocks are beating the market so far in 2020, you're right. Moderna has been a much bigger winner than AstraZeneca year to date. But which of these coronavirus stocks is the better long-term pick? 

Image source: Getty Images.

Continue reading

Source Fool.com